The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).
 
Nusayba Ali Bagegni
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Xcovery (Inst)
 
Leslie Nehring
No Relationships to Disclose
 
Jill Anderson
No Relationships to Disclose
 
Brittney Haas
No Relationships to Disclose
 
Jingqin Luo
No Relationships to Disclose
 
Meghna S. Trivedi
No Relationships to Disclose
 
Laura Carpin Kennedy
No Relationships to Disclose
 
Manali A. Bhave
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Merck
 
Karen Colleen Daily
Consulting or Advisory Role - Pfizer
 
Wajeeha Razaq
No Relationships to Disclose
 
Yiling Lu
No Relationships to Disclose
 
Wei-Lien Wang
No Relationships to Disclose
 
Gerburg M. Wulf
Stock and Other Ownership Interests - Selecta Biosciences (I)
Research Funding - GlaxoSmithKline (Inst); Merck
Patents, Royalties, Other Intellectual Property - Pin1 as a marker for abnormal cell growth Patent number: 8129131; Pin1 inhibitors (Inst)
 
Rabih Said
Employment - GlaxoSmithKline (I)
 
Cynthia X. Ma
Consulting or Advisory Role - Agendia; AstraZeneca; Athenex; Bayer; Biovica; Eisai; Gilead Sciences; Inivata; Jacobio; Natera; Novartis; Olaris; Philips Electronics; Puma Biotechnology; Sanofi; Seagen
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)